Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tiotropium HandiHaler versus placebo in maintenance-therapy-naive COPD
2006-006276-38Phase 4Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Feb 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in chronic obstructive pulmonary disease (COPD) comparing Tiotropium plus PRN albuterol with Placebo plus PRN albuterol (2 arms). Primary endpoint: FEV1 AUC(0-3h) post-dose response at week 24. Started Feb 2007; status: completed.
02
Drugs
tiotropium
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on 2006-006276-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-006276-38.